focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix announces the new UV COBRA Cure FX4

14 Sep 2021 07:00

RNS Number : 6230L
ProPhotonix Limited
14 September 2021
 

 

September 14th, 2021

RNS REACH

ProPhotonix Limited

("ProPhotonix" or "the Company")

ProPhotonix Launches Powerful New UV LED Curing System - The COBRA Cure FX4

A reimagined form factor with optimized airflow and multiple integration options

 

 

ProPhotonix Limited, (London Stock Exchange - AIM: PPIX; OTC: STKR), a designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the United Kingdom, today announces an exciting addition to their range of UV LED Curing systems - The COBRA Cure FX4.

The COBRA Cure FX4 is a compact, UV LED lamp solution that can be used for small to large format digital printers as well as high speed, single pass industrial print or coatings applications. With COBRA Cure FX4, the entire UV LED lamp has been optimized to produce an ideal cure offering equipment manufacturers the opportunity to gain a competitive edge.

 

Using high-density Chip-on-Board LED arrays, the COBRA Cure FX4 delivers intensities up to 14 W/cm2 and energy densities (dose) of up to 58 mJ/cm2 without any compromise on lifetime. It comes in four wavelengths - 365nm, 385nm, 395nm and 405nm. The product includes a wide 40mm window ensuring uniform UV light and maximum dwell time. The FX4 is available in 75mm module segments up to any length with high uniformity (>90%) across the entire length of the lamp.

 

High intensity lamps often produce large volumes of hot air - which can interfere with the final cure. In designing COBRA Cure FX4, ProPhotonix' Engineering team has reimagined the form factor of UV LED Curing systems by designing the FX4's airflow such that it avoids the need for any ancillary ducting or valuable space for clearance. To ease installation, the team has also integrated two aluminum T-slot profiles into the FX4 chassis providing an industry leading mounting range of 200mm.

 

Demand for LED technology has also been driven by the increasing safety and environmental concerns associated with using mercury-based curing. UV LEDs are ozone and heavy metal -free making them a safer, more environmentally sustainable option. The on/off functionality is more energy efficient and they have a longer lifetime and total lower cost when compared to mercury-based systems.

"Our engineers longstanding experience with high-density LEDs has really driven the innovation behind this product. The changes our engineering team has made will allow for faster line speeds on a wide selection of applications. It will also allow specifiers that have yet to convert to UV LED lamps due to insufficient optical power to unlock the advantages of a high powered UV LED solution" said Tim Losik, President and CEO of ProPhotonix.

 

For more information download the Cobra Cure FX4 datasheet at: https://www.prophotonix.com/led-and-laser-products/uv-led-curing-systems/cobra-cure-fx4/

 

Contact:

 

ProPhotonix Limited

Ken Reynolds,

Business and Technology Manager, ProPhotonix

 

Tel: +353(0) 21 5001315

kreynolds@prophotonix.com

WH Ireland Limited

 

Katy Mitchell

Ben Good

Nominated Adviser and Broker

Tel: +44 (0) 20 7220 1666

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDCBDBDGBX
Date   Source Headline
13th Aug 20127:00 amRNSHalf Yearly Report
25th May 20122:30 pmRNSGrant of Options (Replacement)
17th May 20127:00 amRNSAGM Statement
1st May 20124:21 pmRNSPosting of Annual Report and Accounts
5th Apr 20127:00 amRNSAppointment of Three New Distribution Partners
26th Mar 20127:00 amRNSGrant of Options
19th Mar 20127:00 amRNSAppointment of Joint Broker
1st Mar 20127:00 amRNSFinal Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
19th Jan 20127:00 amRNSTrading Update and New Product Launch
27th Oct 20117:00 amRNS3rd Quarter Results
28th Jul 20117:00 amRNSHalf Yearly Report
20th Jul 20117:00 amRNSNotice of Results
13th Jul 20117:00 amRNSIssue of Equity
26th May 20111:51 pmRNSDirector/PDMR Shareholding
24th May 20115:09 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSChange of Adviser
4th May 20117:00 amRNS1st Quarter Results
19th Apr 20115:28 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.